MedTrace Logo

Intermittent Pneumatic Compression for Treating Lower Limb Lymphoedema

NCT03856281 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-01-27

No results posted yet for this study

Summary

The treatment of lymphoedema and its associated complications represent a considerable drain on increasingly limited NHS resources. Intermittent pneumatic compression (IPC) represents an innovative treatment for this condition, however the efficacy of IPC as a treatment for lower limb lymphoedema needs to be investigated via robust clinical research.

Conditions

  • Lymphoedema of Leg

Interventions

DEVICE

Intermittent Pneumatic Compression

Participants administer an intermittent pneumatic compression device in addition to their standard lymphoedema care for a 5 week treatment period

Sponsors & Collaborators

  • University of South Wales

    collaborator OTHER

  • Cwm Taf University Health Board (NHS)

    lead OTHER_GOV

Principal Investigators

  • Mark Williams, PhD · University of South Wales

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-10
Primary Completion
2019-12-10
Completion
2019-12-10

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03856281 on ClinicalTrials.gov